Announcements Trials
Browse Landscape

Phase

Phase 2 8Phase 3 4Phase NA 1Phase 1 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Vomiting 1Ovarian Neoplasms 1Nausea 1Lung Neoplasms 1Infiltrating Bladder Urothelial Carcinoma 1Fallopian Tube Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Brenner Tumor 1

Interventions

Early Intervention, Educational 30Educational Status 29Blood Specimen Collection 28Standard of Care 27Methods 25Exercise 20Magnetic Resonance Spectroscopy 19Radiosurgery 18Practice Guidelines as Topic 18Surveys and Questionnaires 17X-Rays 16Tomography, X-Ray Computed 13Radiotherapy 11Interviews as Topic 11Biopsy 11Specimen Handling 10Fluorodeoxyglucose F18 10Patient Navigation 9Bronchoscopy 9Thoracic Surgery, Video-Assisted 8Therapeutics 8Saline Solution 7Psychiatric Rehabilitation 7Palliative Care 7Control Groups 7Breathing Exercises 7Acupuncture Therapy 7Drug Therapy 6Cryosurgery 6Counseling 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Lung Neoplasms × 1,2-diaminocyclohexaneplatinum II citrate × Clear all
NCT02194738 2026-05-29

Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)

National Cancer Institute (NCI)

Phase NA Active not recruiting
8,300 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡